AUGMENTATION

Clinical trials for AUGMENTATION explained in plain language.

Never miss a new study

Get alerted when new AUGMENTATION trials appear

Sign up with your email to follow new studies for AUGMENTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New hope for restless leg sufferers: drug may ease treatment side effects

Symptom relief Completed

This early-stage study tested whether ecopipam can reduce symptoms in people whose restless leg syndrome got worse from standard dopamine drugs. Ten adults took ecopipam or a placebo for six weeks, then switched. The goal was to see if the drug could ease leg discomfort and sleep…

Matched conditions: AUGMENTATION

Phase: PHASE1, PHASE2 • Sponsor: William Ondo, MD • Aim: Symptom relief

Last updated May 15, 2026 11:53 UTC

AUGMENTATION

Get alerted when new AUGMENTATION trials appear

New hope for restless leg sufferers: drug may ease treatment side effects